Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Karen Klahr Miller, M.D.

Co-Author

This page shows the publications co-authored by Karen Miller and David Herzog.
Connection Strength

1.921
  1. A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women With Anorexia Nervosa. J Clin Endocrinol Metab. 2019 10 01; 104(10):4347-4355.
    View in: PubMed
    Score: 0.209
  2. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011 Jul; 96(7):2081-8.
    View in: PubMed
    Score: 0.117
  3. Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. J Clin Endocrinol Metab. 2009 Apr; 94(4):1367-71.
    View in: PubMed
    Score: 0.100
  4. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone. 2008 Jul; 43(1):135-139.
    View in: PubMed
    Score: 0.094
  5. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry. 2007 Jun; 68(6):959-65.
    View in: PubMed
    Score: 0.089
  6. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab. 2007 Apr; 92(4):1334-9.
    View in: PubMed
    Score: 0.087
  7. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab. 2006 Aug; 91(8):2931-7.
    View in: PubMed
    Score: 0.083
  8. Medical findings in outpatients with anorexia nervosa. Arch Intern Med. 2005 Mar 14; 165(5):561-6.
    View in: PubMed
    Score: 0.076
  9. Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa. Psychiatry Res. 2004 Dec 30; 132(3):197-207.
    View in: PubMed
    Score: 0.075
  10. Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab. 2004 Sep; 89(9):4434-8.
    View in: PubMed
    Score: 0.074
  11. Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2004 Aug; 89(8):3903-6.
    View in: PubMed
    Score: 0.073
  12. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab. 2014 Apr; 99(4):1322-9.
    View in: PubMed
    Score: 0.035
  13. Psychotropic medication use in anorexia nervosa between 1997 and 2009. Int J Eat Disord. 2012 Dec; 45(8):970-6.
    View in: PubMed
    Score: 0.032
  14. Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol (Oxf). 2012 Apr; 76(4):520-5.
    View in: PubMed
    Score: 0.031
  15. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res. 2011 Oct; 26(10):2430-8.
    View in: PubMed
    Score: 0.030
  16. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry. 2011 Nov; 72(11):1546-51.
    View in: PubMed
    Score: 0.030
  17. Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol. 2011 Feb; 164(2):253-61.
    View in: PubMed
    Score: 0.028
  18. Use of SSRIs may Impact Bone Density in Adolescent and Young Women with Anorexia Nervosa. CNS Spectr. 2010 Sep; 15(9):579-586.
    View in: PubMed
    Score: 0.028
  19. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010 Nov; 95(11):4889-97.
    View in: PubMed
    Score: 0.028
  20. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab. 2009 Dec; 94(12):4710-6.
    View in: PubMed
    Score: 0.026
  21. Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone. 2009 Jul; 45(1):104-9.
    View in: PubMed
    Score: 0.025
  22. Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents. Am J Clin Nutr. 2008 Dec; 88(6):1478-84.
    View in: PubMed
    Score: 0.025
  23. Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab. 2008 Aug; 93(8):3029-36.
    View in: PubMed
    Score: 0.024
  24. Determinants of height in adolescent girls with anorexia nervosa. Pediatrics. 2008 Jun; 121(6):e1517-23.
    View in: PubMed
    Score: 0.024
  25. Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics. 2008 Jun; 121(6):1127-36.
    View in: PubMed
    Score: 0.024
  26. Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab. 2008 Apr; 93(4):1292-7.
    View in: PubMed
    Score: 0.023
  27. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab. 2008 Apr; 93(4):1231-7.
    View in: PubMed
    Score: 0.023
  28. Hormonal and nutritional effects on cardiovascular risk markers in young women. J Clin Endocrinol Metab. 2007 Aug; 92(8):3089-94.
    View in: PubMed
    Score: 0.022
  29. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab. 2007 Jun; 92(6):2046-52.
    View in: PubMed
    Score: 0.022
  30. Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa. J Pediatr. 2006 Dec; 149(6):763-769.
    View in: PubMed
    Score: 0.021
  31. Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr. 2006 Oct; 84(4):698-706.
    View in: PubMed
    Score: 0.021
  32. Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res. 2006 Apr; 59(4 Pt 1):598-603.
    View in: PubMed
    Score: 0.021
  33. Regional cerebral brain metabolism correlates of neuroticism and extraversion. Depress Anxiety. 2006; 23(3):133-8.
    View in: PubMed
    Score: 0.020
  34. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2006 Mar; 91(3):1027-33.
    View in: PubMed
    Score: 0.020
  35. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab. 2005 Sep; 90(9):5082-7.
    View in: PubMed
    Score: 0.019
  36. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab. 2005 Sep; 289(3):E373-81.
    View in: PubMed
    Score: 0.019
  37. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab. 2005 Aug; 289(2):E347-56.
    View in: PubMed
    Score: 0.019
  38. Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab. 2005 May; 90(5):2580-7.
    View in: PubMed
    Score: 0.019
  39. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics. 2004 Dec; 114(6):1574-83.
    View in: PubMed
    Score: 0.019
  40. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2004 Oct; 89(10):4972-80.
    View in: PubMed
    Score: 0.018
  41. Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. J Clin Endocrinol Metab. 2004 Aug; 89(8):3988-93.
    View in: PubMed
    Score: 0.018
  42. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab. 2004 Jul; 89(7):3486-95.
    View in: PubMed
    Score: 0.018
  43. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab. 2004 Apr; 89(4):1605-12.
    View in: PubMed
    Score: 0.018
  44. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2003 Dec; 88(12):5615-23.
    View in: PubMed
    Score: 0.017
  45. Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2003 Aug; 88(8):3816-22.
    View in: PubMed
    Score: 0.017
  46. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study. J Clin Endocrinol Metab. 2003 Mar; 88(3):1142-9.
    View in: PubMed
    Score: 0.017
  47. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med. 2000 Nov 21; 133(10):790-4.
    View in: PubMed
    Score: 0.014
  48. Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord. 2000 Nov; 28(3):284-92.
    View in: PubMed
    Score: 0.014
  49. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab. 1999 Jun; 84(6):2049-55.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.